Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events eu grants largest project safety evaluation drugs used treatment diabetes
… broad and includes all technology, products, and services used for patient care, treatment, diagnosis, monitoring, or health improvement – …
… a Marketing Specialist with RTI-HS. Ms. Howze’s focus is events, project managements, and content creation. She has a … su ch as The Washington Post , The Huffington Post , U.S. News & World Report , and MTV News. …
… it also needs to be balanced, and for example, present all safety data and a thorough review of the clinical evidence. … is more akin to a global reimbursement dossier and may be used as a template to develop a dossier for direct use by … payers—during the value message development phase of the project. For markets of interest, we would suggest either …
Real-World Comparative Effectiveness Analysis for Use in Cost-Effectiveness Modeling in Multiple Sclerosis …
… teams for multiyear, multidatabase postauthorization drug safety studies, using data sources from the United States … a variety of therapeutic areas, including oncology, type 2 diabetes, dementia, and psychosis. Prior to joining RTI-HS, …
… PA Hilary Smith, MSPH, is a Research Epidemiologist/Project Manager in the Pharmacoepidemiology and Risk … health projects and research teams. Her experience in project management includes coordinating international … and coordinating an office-based substance use disorder treatment program in Boston, Massachusetts. …
… 2024. Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments …
… 7, 10:30am - 12:00pm EST Considerations for planning safety surveillance studies of COVID-19 vaccines Alicia …
… of China Yi-Chun Lin, MSc, is a Health Economist in the EU modelling team at RTI-HS. Before joining RTI-HS, she … on incorporating socioeconomic variations into economic evaluation, using distributional cost-effectiveness analysis. …
… diseases? How do HTA bodies appraise rare disease drugs? What are the key challenges to developing …